PRKAA2 and psoriasis: Typically, CISD1 (p = 3.9e-10), TRIB2 (p < 2.22e−16), and ABCC5 (p=0.0012) levels among psoriasis cases increased compared with healthy controls, whereas PRKAA2 (p < 2.22e−16), ACSF2 (p = 3e−15), TIMM9 (p= 0.049), PEBP1 (p < 2.22e−16) and NR5A2 (p=1.8e−13) levels decreased among psoriasis cases (Figure 5).